Cencora management check

COR · Health Care · Health Care Distributors · CEO Robert P. Mauch

Filings as of

63
Management score, ranked 268th of 487 · 29th of 60 in Health Care3 good · 3 to watch · 1 flaggedStrongest: owner returns · Weakest: stable leadership · Best and worst run in Health Care →

Closest peers in Health Care Distributors

  1. 46CAHCardinal Health81
  2. 144MCKMcKesson72
  3. 261MRKMerck & Co.64
  4. 268CORCencora63
  5. 277PFEPfizer63
  6. 448HSICHenry Schein46

The seven checks

  • Good

    Have owners done well?

    Beat its chosen peersOwners$342Peers$144

    What $100 became since fiscal 2021

    100100th
    Detail

    $100 invested at the start of fiscal 2021 grew to $342, against $144 for the peer group the company picked itself.

  • Watch

    Does pay follow performance?

    Pay only loosely tracked returns20212025

    Pay actually paid $100 value, each on its own scale

    6019th
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.21 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Watch

    What does the CEO cost owners?

    1.2% of net income

    $18.3m pay · $1.6bn net income, FY2025

    0.1%1%3%10%
    4545th
    Detail

    $18.3m of reported pay in fiscal 2025, against $1.6bn of net income.

  • Watch

    Do they own the stock?

    CEO stake ≈ 2.0 years of pay

    103,375 shares ≈ $36.1m

    0.1y1y5y20y100y

    6 mo: ▲ $2.3m bought · ▼ $5.0m sold

    5056th
    Detail

    The CEO holds 103,375 shares, directly or through trusts (unvested awards not counted): about 2.0 years of pay. Both: 2 buyers ($2.3m) and 3 sellers ($5.0m) in six months. 3 of 5 sales ran on pre-arranged 10b5-1 plans.

  • Good

    Are owners being diluted?

    Share count shrinking2021 · 208m2025 · 195m

    Diluted shares −2.3% a year; flagged above +2%

    0%10%20%

    Stock pay 0.0% of revenue

    7971st
    Detail

    Diluted shares changed -2.3% a year over the last three fiscal years. Stock-based pay was 0.0% of revenue in the latest year.

  • Flag

    Is leadership stable?

    2 CEOs in the pay table

    15 filings under 8-K 5.02 in 3 years

    0101420+

    CEOs: Steven H. Collis, Robert P. Mauch

    107th
    Detail

    CEOs in the pay table: Steven H. Collis, Robert P. Mauch. 15 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed January 22, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
$0$30.7m$61.4m$10020212022202320242025$342$144

Pay tied most to Adjusted EPS

Other key measuresAdjusted Operating Income*Adjusted EPS*Adjusted Free Cash Flow*Adjusted ROIC*

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025Robert P. Mauch$18.3m$33.9m$6.1m$342$144$1.6bn
2024Steven H. Collis$18.5m$61.4m$7.8m$244$156$1.5bn
2023Steven H. Collis$17.5m$33.8m$5.1m$193$128$1.7bn
2022Steven H. Collis$16.7m$26.1m$4.4m$144$118$1.7bn
2021Steven H. Collis$14.9m$39.8m$4.6m$125$123$1.5bn

Insiders and the CEO's stakeMixed

President & CEO
Robert P. Mauch
Shares held
103,375
At that filing's price
≈ $36.1m
Latest Form 4
Nov 12, 2026

Both: 2 buyers ($2.3m) and 3 sellers ($5.0m) in six months. 3 of 5 sales ran on pre-arranged 10b5-1 plans.

Open-market trades by officers and directors since May 21, 2026.

  • BoughtDermot Mark DurcanDirector$2.2mJun 18, 2026
  • BoughtLauren M TylerDirector$149kJun 22, 2026
  • SoldElizabeth S CampbellExecutive Vice President$3.7mAug 24, 2026
  • SoldLazarus KrikorianSVP & Chief Accounting Officer · 10b5-1 plan$946kNov 2, 2026

Leadership and governance on file

20222023202420252026Leadership 22Votes 5
All 22 filings

Latest shareholder vote results: Mar 6, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $5.7bn returned to owners in buybacks and dividends, 71% of net income, and $613.6m of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$953.8m$1.9bn20212022202320242025Shares208m211m205m200m195m
Show the figures
Fiscal year20212022202320242025
Revenue$214.0bn$238.6bn$262.2bn$294.0bn$321.3bn
Net income$1.5bn$1.7bn$1.7bn$1.5bn$1.6bn
Stock-based pay$99.6m$93.4m$124.6m$148.0m$148.0m
Buybacks$82.2m$483.7m$1.2bn$1.5bn$435.5m
Dividends$366.6m$391.7m$398.8m$416.2m$437.1m
Diluted shares208m211m205m200m195m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.